StonvexLoading…
StonvexStonvexStonvexCore line items from INM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-06-30 | Q1 2022 2022-03-31 | Q4 2021 2021-12-31 | Annual 2021 2021-06-30 |
|---|---|---|---|---|
Revenue | $1.37M | $574.68K | $265.09K | $1.90M |
Operating Income | $-18.60M | $-10.73M | $-7.25M | $-10.20M |
Net Income | $-18.60M | $-10.73M | $-7.25M | $-10.20M |
EPS (Diluted) | $-33.17 | $-20.13 | $-14.03 | $-37.96 |
Total Assets | $12.79M | $15.49M | $19.38M | $9.78M |
Total Liabilities | $3.71M | $4.60M | $5.22M | $2.40M |
Cash & Equivalents | $6.18M | $5.90M | $11.28M | $7.36M |
Free Cash Flow OCF − CapEx | $-15.62M | $-11.58M | $-6.22M | $-9.79M |
Shares Outstanding | 650.67K | 14.28M | 14.14M | 322.03K |